Nantahala Capital Management »

Aptose Biosciences shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Aptose Biosciences (APTO) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Aptose Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aptose Biosciences held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptose Biosciences by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $305k 120k 2.54
2023-09-30 $382k 137k 2.80
2023-06-30 $679k 146k 4.64

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Aptose Biosciences

DRW Holdings
Nantahala Capital Management
Sigma Planning
Citadel Advisors
Two Sigma Securities
Texas Capital Bank Wealth Management Services
UBS Group
TD Waterhouse Canada
Royal Bank of Canada
Us Bancorp
Gleason Group
Newbridge Financial Services Group
Advisor Group Holdings
HighMark Wealth Management
Beaird Harris Wealth Management

View all funds holding Aptose Biosciences